ZEMDRI
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ZEMDRI, covering 2018-06-25 to 2023-02-10. Get the full timeline:
Most recent: FDA Approved: ZEMDRI (PLAZOMICIN) — Supplemental Application (Cipla Therapeutics Inc.)